Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$246,520
-$1,818,660 QoQ
Shares Held
1,573
-88.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,221
of 1,603 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026V-Square Quantitative Management LLC holds $55,023,385 across 13 Drug Manufacturers - General names. NVS ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,994 | $20,383,115 | |
| 2 | JNJ |
Johnson & Johnson
|
54,440 | $13,826,126 | |
| 3 | MRK |
Merck & Co., Inc.
|
46,239 | $5,941,711 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
28,176 | $3,559,755 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
52,713 | $3,037,323 | |
| 6 | ABBV |
AbbVie Inc.
|
11,211 | $2,821,136 | |
| 7 | GSK |
GSK plc
|
42,017 | $2,202,531 | |
| 8 | BIIB |
Biogen Inc.
|
4,349 | $939,644 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,520 | 1,573 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,065,180 | 13,520 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,720,617 | 12,480 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,541,573 | 12,021 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,432,395 | 11,837 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,299,522 | 11,657 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,087,244 | 11,173 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $993,197 | 8,635 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $919,282 | 8,635 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $812,048 | 8,395 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $847,643 | 8,395 | Shares | Sole | 2024-02-21 | |
| No filing history on record for this holder in this stock. | ||||||